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Abstract
Background: Cellulitis caused by Mycobacterium avium-intracellulare has rarely been described.
Mycobacterium avium-intracellulare is a rare cause of septic arthritis after intra-articular injection,
though the causative role of injection is difficult to ascertain in such cases.
Case presentation: A 57-year-old with rheumatoid arthritis treated with prednisone and
azathioprine developed bilateral painful degenerative shoulder arthritis. After corticosteroid
injections into both acromioclavicular joints, he developed bilateral cellulitis centered over the
injection sites. Skin biopsy showed non-caseating granulomas, and culture grew Mycobacterium
avium-intracellulare. Joint aspiration also revealed Mycobacterium avium-intracellulare infection.
Conclusion: Although rare, skin and joint infections caused by Mycobacterium avium-intracellulare
should be considered in any immunocompromised host, particularly after intra-articular injection.
Stains for acid-fast bacilli may be negative in pathologic samples even in the presence of infection;
cultures of tissue specimens should always be obtained.
Background
Mycobacterium avium-intracellulare (MAI) is a common
cause of disseminated disease among patients with
human immunodeficiency virus (HIV) infection [1], and
also occasionally causes pulmonary infections, lymphad-
enitis, and osteomyelitis in other immunocompromised
as well as immunocompetent hosts [2].
Cutaneous disease caused by MAI has a wide variety of
clinical presentations, including nodules, pustules, ulcers,
abscesses, and draining sinuses [2-4]. Cutaneous MAI usu-
ally occurs as a manifestation of disseminated disease.
Cellulitis as a primary cutaneous manifestation is rare [4].
MAI septic arthritis has been described in immunocompe-
tent patients [5-7], as well as in patients immunosup-
pressed by cancer, connective tissue disease, kidney
transplant, and HIV [7-10]. MAI septic arthritis has been
described after joint injection, however the causative role
of the injection is difficult to ascertain [5,10].
We describe a patient with rheumatoid arthritis receiving
prednisone and azathioprine who, after corticosteroid
injections into both acromioclavicular joints, developed
bilateral cellulitis centered over the injection sites and left
shoulder septic arthritis.
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Case Presentation
Clinical history
A 57-year-old Caucasian male was first seen by a rheuma-
tologist in 1998 for arthralgias and myalgias of his proxi-
mal upper extremities. His medical history included
obesity and hypertension. There was no family history of
rheumatologic disease. He worked as a glazier, and had
no substance abuse history. Physical examination showed
synovitis of his metacarpophalangeal joints and wrists.
Erythrocyte sedimentation rate was >120 mm/hr, and
rheumatoid factor was negative. He was diagnosed with
seronegative rheumatoid arthritis, and prednisone was
initiated at 10 mg daily in 1999. His arthralgias and myal-
gias responded clinically to the prednisone.
In late 1999, because of new symptoms of fatigue, weight
loss, and fevers, 10 mg of weekly methotrexate was added
to his regimen. An infectious disease consultation was
obtained to rule out infection as a cause of his symptoms,
and an extensive workup was performed. A chest radio-
graph was normal, and computed tomography (CT) scans
of the abdomen and pelvis were unremarkable. A bone
marrow biopsy was normal and cultures for bacteria,
mycobacteria, and fungi were negative. Multiple blood
cultures for bacteria were negative. With the exception of
a persistently elevated sedimentation rate of 133 mm/hr,
laboratory results were normal, and no infectious etiology
for his symptoms could be found. Because of a lack of
response, his methotrexate was discontinued after 3
months of therapy. His weight loss and fevers stopped,
and only his fatigue continued.
In January 2002, still on oral prednisone, he was diag-
nosed with degenerative arthritis of both shoulders. His
prednisone was increased to 15 mg daily, and azathio-
prine 100 mg daily was added. In April 2002, his left
acromioclavicular joint was injected with a corticosteroid
for symptomatic relief. In June 2002, both acromioclavic-
ular joints were injected with corticosteroids. In Decem-
ber 2002, he first noted an erythematous, warm rash that
began simultaneously on both shoulders at the sites of his
shoulder injections.
In April 2003, he transferred his rheumatological care to
our institution. His immunosuppressant regimen con-
sisted of prednisone 10 mg daily, azathioprine 100 mg
daily, and hydroxychloroquine 200 mg twice daily. He
complained of fevers, fatigue, worsening bilateral shoul-
der pain, and progressive bilateral shoulder rash. In addi-
tion, he noted new dyspnea without cough. His shoulder
pain now prevented him from carrying objects and per-
forming his job. His left shoulder rash, shown in Figure 1,
was macular, warm, erythematous, non-tender, and
blanched with pressure. At its center was a 5-centimeter
crusted ulcer with modest serosanguinous drainage, over-
lying the acromioclavicular joint. The surrounding ery-
thema had progressed to include his entire left breast to
the level of the nipple. It extended slightly onto the left
arm and upper back, and did not cross the midline. On
the right shoulder, there was a 5-centimeter circular patch
of mottled erythema and warmth without ulceration or
drainage, overlying the right acromioclavicular joint and
symmetric with the central focus of the left-sided rash.
There was no appreciable lymphadenopathy. Physical
examination of the shoulders was limited by pain with
both active and passive range of motion in all directions.
There was a palpable effusion of the left shoulder, but not
the right. Physical examination of his fingers, wrists,
elbows, knees, ankles, and feet was otherwise normal with
no evidence of synovitis.
The consulting rheumatologist concurred with the origi-
nal diagnosis of seronegative rheumatoid arthritis. How-
ever, due to the presence of the unexplained rash,
alternative and additional diagnoses were considered,
including dermatomyositis, sarcoidosis, cutaneous leuke-
mia or lymphoma, and infection. Erythrocyte sedimenta-
tion rate was >140 mm/hr, and C-reactive protein titer
was 1:16. Anti-nuclear antibodies, uric acid, rheumatoid
factor, C3, and C4 were normal. White blood cell count
was 13,400 cells/mm3 with a neutrophilic predominance,
hemoglobin was 10.6 g/dL and platelet count was
400,000 cells/mm3. Serum albumin was 2.8 gm/dL.
Serum electrolytes, renal function, liver tests, and creatine
kinase were normal. A serum electrophoresis showed pol-
yclonal hypergammaglobulinemia, and ferritin was ele-
vated at 356 ng/ml, suggesting chronic inflammation. A
chest radiograph was normal. A skin biopsy of the left
Left chest and shoulder, with arrow indicating site of prior  injection into or near the acromioclavicular joint Figure 1
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shoulder cellulitis in July 2003 revealed non-caseating
granulomatous inflammation consistent with sarcoidosis.
Stains for fungus and acid-fast bacilli (AFB) were negative,
but cultures were not performed.
He was diagnosed with cutaneous sarcoidosis and treated
with azathioprine 100 mg daily, prednisone 40 mg daily,
and rofecoxib 25 mg daily. Chest CT revealed subtle retic-
ulonodular parenchymal changes with lower lung zone
predominance. Though the CT findings were compatible
with the diagnosis of sarcoidosis, the lower lobe involve-
ment and absence of lymphadenopathy were atypical.
Because the clinical syndrome was not entirely consistent
with sarcoidosis, repeat skin biopsy was performed in Sep-
tember 2003, this time with fungal and AFB cultures in
addition to the routine pathology stains. Once again,
pathology revealed granulomatous inflammation consist-
ent with sarcoidosis with negative fungal and AFB stains.
However, AFB cultures grew mycobacteria after only eight
days. The diagnosis of MAI was made by DNA probe, and
confirmed by culture. Bacterial and fungal cultures were
negative. Serology for HIV was negative.
Antimicrobial therapy consisting of azithromycin, cipro-
floxacin and ethambutol was initiated in December of
2003 by an infectious diseases consultant. Azathioprine
was discontinued and corticosteroids were tapered to 7.5
mg po qd, which was the lowest tolerable dose for the
patient because of a return of his myalgias and arthralgias.
Shoulder plain films and magnetic resonance imaging
(MRI) revealed large joint effusions and evidence for avas-
cular necrosis, greater on the left side (Figure 2). Joint
aspiration of the left shoulder revealed MAI by culture,
and surgical drainage and debridement was performed in
January 2004. Intraoperative findings included multiple
rice bodies within the joint and a large cloudy effusion.
Post-operatively, he was prescribed intravenous amikacin,
which was discontinued after 2 weeks due to the develop-
ment of renal insufficiency. In March 2004, because the
cutaneous lesions over his shoulders continued to
progress despite initiation of antimicrobial therapy and
decrease in immunosuppression, ciprofloxacin was
changed to moxifloxacin, and rifabutin was added to his
regimen.
The patient completed 21 months of multi-drug therapy
with relief but not complete resolution of his rash and
shoulder pain. In September 2005, his azithromycin,
moxifloxacin, ethambutol, and rifabutin were discontin-
ued on a trial basis because of cumulative drug toxicities.
Unfortunately, fevers returned and the rash over the left
anterior shoulder worsened. A repeat aspiration of his left
shoulder confirmed persistence of MAI septic arthritis
with a sensitive isolate. A follow-up CT scan of the chest
showed no progression of his previously seen nodules.
Antimycobacterial therapy has been re-initiated, and he
has undergone a second debridement of his left shoulder.
He has since responded to continued antimicrobial ther-
apy documented by a negative joint aspiration, although
he continues to have severe arthritic pain from permanent
joint damage.
Mechanisms of introduction
One of two possible mechanisms probably explains the
occurrence of MAI in the skin and shoulder. The first pos-
sibility is that MAI was introduced directly into the tissue
at the time of injection. MAI is ubiquitous in the environ-
ment, including water sources, and can contaminate
injectable solutions [11]. Because MAI grows slowly, a six-
month lag between injection and clinical presentation, as
seen in our patient, is biologically plausible. Hoffman et
al estimated that 40% of the 19 patients with septic arthri-
tis due to atypical mycobacteria in his series had had pre-
vious joint injection; however, only 1 of the injected
patients had MAI [12]. It is not reported whether any of
the 7 MAI septic arthritis patients in Kozin et al had been
previously injected or aspirated [7]. Czachor et al reported
a kidney transplant patient who developed MAI septic
arthritis months after a diagnostic arthrocentesis for the
diagnosis of gout [10]. In our patient, the temporal rela-
Coronal fat-suppressed T2-weighted magnetic resonance  image of the left shoulder revealing diffuse synovitis and bur- sitis with a large joint effusion Figure 2
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tionship between the shoulder injections, the subsequent
appearance of simultaneous bilateral MAI skin infections
at the site of the injections, and the eventual occurrence of
left shoulder MAI septic arthritis, provides strong circum-
stantial evidence for the causative role of joint injection in
this patient. Cellulitis of the overlying skin has not been
described in previous reports of MAI septic arthritis [6-
10,12].
The second possibility is that the patient had undiagnosed
disseminated MAI at the time of joint injection, and the
trauma of injection caused concentration of the organ-
isms at the injection sites. There is some evidence that this
phenomenon occurs in patients with disseminated MAC.
Freed et al reported a case of MAI soft tissue infection doc-
umented post-mortem at an IV injection site in an HIV-
and MAI-infected patient [3]. Meadows et al reported an
abscess due to MAI at the site of an intramuscular injec-
tion in an HIV-infected patient [13]. Prior to intra-articu-
lar injection, our patient had been treated with
corticosteroids for approximately 3 years as well as short-
term methotrexate and azathioprine. While this degree of
immunosuppression makes disseminated MAI possible,
there is little evidence to support the theory of pre-existing
undiagnosed disseminated MAI infection in our patient,
though it remains a possibility. Another possibility may
be increased susceptibility to mycobacterial disease due to
an underlying genetic defect in the IFN-γ response path-
way [14].
Conclusion
This case illustrates an unusual presentation of MAI: both
cellulitis and septic arthritis after bilateral shoulder joint
injections. When MAI infects the skin, it typically causes
nodules, pustules, and ulcers, but rarely cellulitis [2-4]. It
is important to maintain suspicion of atypical mycobacte-
ria in infections of immunocompromised patients, partic-
ularly in those undergoing diagnostic and therapeutic
procedures. Cultures of biopsied skin should be per-
formed, as special stains for AFB may be negative even in
the presence of MAI infection. As with other mycobacte-
ria, the clinical spectrum of MAI is broad, and it should be
included in the differential diagnosis of skin and joint
infections.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
DM conceived the study. Both authors participated in data
acquisition and wrote the manuscript. Both authors have
seen and approved the final manuscript.
References
1. Rubin DS, Rahal JJ: Mycobacterium-avium complex.  Infect Dis Clin
North Am 1994, 8:413-426.
2. Wolinsky E: Nontuberculous mycobacteria and associated dis-
eases.  Am Rev Resp Dis 1979, 119:107-159.
3. Freed JA, Pervez NK, Chen V, Lebwohl M, Damsker B: Cutaneous
mycobacteriosis: Occurrence and significance in two
patients with the acquired immunodeficiency syndrome.
Arch Dermatol 1987, 123:1601-1603.
4. Friedman BF, Edwards D, Kirkpatrick CH: Mycobacterium avium-
intracellulare : cutaneous presentations of disseminated dis-
ease.  Am J Med 1988, 85:257-263.
5. Hellinger WC, Smilack JD, Greider JL Jr, Alvarez S, Trigg SD, Brewer
NS, Edson RS: Localized soft-tissue infections with Mycobacte-
rium avium/Mycobacterium intracellulare complex in immuno-
competent patients: granulomatous tenosynovitis of the
hand or wrist.  Clin Infect Dis 1995, 21:65-69.
6. Frosch M, Roth J, Ullrich K, Harms E: Successful treatment of
Mycobacterium avium osteomyelitis and arthritis in a non-
immunosuppressed child.  Scand J Infect Dis 2000, 32:328-329.
7. Kozin SH, Bishop AT: Atypical mycobacterium infections of the
upper extremity.  J Hand Surg [Am] 1994, 19:480-487.
8. Vinetz JM, Rickman LS: Chronic arthritis due to Mycobacterium
avium  complex infection in a patient with the acquired
immunodeficiency syndrome.  Arthritis Rheum 1991, 34:1339-40.
9. Sheppard DC, Sullam PM: Primary septic arthritis and osteomy-
elitis due to Mycobacterium avium complex in a patient with
AIDS.  Clin Infect Dis 1997, 25:925-926.
10. Czachor JS, Gopalakrishnan R: Coexistent gout and Mycobacte-
rium avium-intracellulare arthritis in a renal transplant recip-
ient.  Kidney Blood Press Res 1997, 20:62-63.
11. Squier C, Yu VL, Stout JE: Waterborne nosocomial infections.
Curr Infect Dis Rep 2000, 2:490-496.
12. Hoffman GS, Myers RL, Stark FR, Thoen CO: Septic arthritis asso-
ciated with Mycobacterium avium : a case report and litera-
ture review.  J Rheumatol 1978, 5:199-209.
13. Meadows JR, Carter R, Katner HP: Cutaneous Mycobacterium
avium complex infection at an intramuscular injection site in
a patient with AIDS.  Clin Infect Dis 1997, 24:1273-1274.
14. Kampmann B, Hemingway C, Stephens A, Davidson R, Goodsall A,
Anderson S, Nicol M, Schölvinck E, Relman D, Waddell S, Langford P,
Sheehan B, Semple L, Wilkinson KA, Wilkinson RJ, Ress S, Hibberd M,
Levin M: Acquired predisposition to mycobacterial disease
due to autoantibodies to IFN-γ.  J Clin Invest 2005,
115:2480-2488.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2334/7/9/prepub